Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Related Citations for PubMed (Select 21251810)

1.

Switching TGFβ from a tumor suppressor to a tumor promoter.

Inman GJ.

Curr Opin Genet Dev. 2011 Feb;21(1):93-9. doi: 10.1016/j.gde.2010.12.004. Epub 2011 Jan 19. Review.

PMID:
21251810
2.

Escaping from the TGFbeta anti-proliferative control.

Seoane J.

Carcinogenesis. 2006 Nov;27(11):2148-56. Epub 2006 May 12. Review.

3.

TGFbeta and cancer metastasis: an inflammation link.

Yang L.

Cancer Metastasis Rev. 2010 Jun;29(2):263-71. doi: 10.1007/s10555-010-9226-3. Review.

PMID:
20437081
4.

Targeting TGFbeta-mediated processes in cancer.

Romano MF.

Curr Opin Drug Discov Devel. 2009 Mar;12(2):253-63. Review.

PMID:
19333871
5.

Targeting TGFbeta signaling for cancer therapy.

Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P.

Cancer Biol Ther. 2005 Mar;4(3):261-6. Epub 2005 Mar 28. Review.

6.

Inhibition of TGFβ signaling and its implications in anticancer treatments.

Calone I, Souchelnytskyi S.

Exp Oncol. 2012;34(1):9-16. Review.

PMID:
22453142
7.

Roles of TGFbeta in metastasis.

Padua D, Massagué J.

Cell Res. 2009 Jan;19(1):89-102. doi: 10.1038/cr.2008.316. Review.

PMID:
19050696
8.

Tumor-suppressive and promoting function of transforming growth factor beta.

Sun L.

Front Biosci. 2004 May 1;9:1925-35. Review.

PMID:
14977598
9.

TGFbeta-regulated transcriptional mechanisms in cancer.

Ellenrieder V, Buck A, Gress TM.

Int J Gastrointest Cancer. 2002;31(1-3):61-9. Review.

PMID:
12622416
10.

Inhibiting breast cancer progression by exploiting TGFbeta signaling.

Baxley SE, Serra R.

Curr Drug Targets. 2010 Sep;11(9):1089-102. Review.

PMID:
20545612
11.

Role of TGFbeta signaling in skin carcinogenesis.

Wang XJ.

Microsc Res Tech. 2001 Feb 15;52(4):420-9. Review.

PMID:
11170301
12.

TGFbeta in Cancer.

Massagué J.

Cell. 2008 Jul 25;134(2):215-30. doi: 10.1016/j.cell.2008.07.001. Review.

13.

Transforming growth factor-beta in cancer and metastasis.

Jakowlew SB.

Cancer Metastasis Rev. 2006 Sep;25(3):435-57. Review.

PMID:
16951986
14.

Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.

Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, Muiru GT, Murphy A, Higgins LS, Chakravarty S, Wong DH.

Mol Pharmacol. 2007 Jul;72(1):152-61. Epub 2007 Mar 30.

15.

TGFbeta signalling: a complex web in cancer progression.

Ikushima H, Miyazono K.

Nat Rev Cancer. 2010 Jun;10(6):415-24. doi: 10.1038/nrc2853. Review.

PMID:
20495575
16.

Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.

Sato S, Futakuchi M, Ogawa K, Asamoto M, Nakao K, Asai K, Shirai T.

Cancer Sci. 2008 Feb;99(2):316-23. doi: 10.1111/j.1349-7006.2007.00690.x.

PMID:
18271931
17.

Context-dependent action of transforming growth factor β family members on normal and cancer stem cells.

Caja L, Kahata K, Moustakas A.

Curr Pharm Des. 2012;18(27):4072-86. Review.

PMID:
22630079
18.

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.

Oft M, Heider KH, Beug H.

Curr Biol. 1998 Nov 19;8(23):1243-52.

19.
20.

The TGFBeta pathway as a therapeutic target in cancer.

Seoane J.

Clin Transl Oncol. 2008 Jan;10(1):14-9. Review.

PMID:
18208788
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk